secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001104659-26-036862
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrana Health files interim financials of acquired Prospect entities; pro forma included
--------------------------------------------------------------------------------

- Acquired Business (PHPH & RI Market) nine-month net loss $38.7M vs $43.7M year-ago; total net revenue $961.8M (+9.6% YoY).
- Operating income $48.5M vs $88.4M YoY; interest expense $121.8M drove pre-tax loss $73.4M.
- Members' deficit $1.31B as of June 30, 2025, with long-term debt $777.8M and current debt $489.0M.
- Pro forma condensed combined statement of operations for Astrana for fiscal year 2025 filed as Exhibit 99.2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465926036862/0001104659-26-036862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465926036862/tm269272d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-036862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer